Cynapsus Therapeutics Reports 2014 Annual Results
TORONTO--(BUSINESS WIRE)--Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson’s disease, today announced financial results for the year ended December 31, 2014. Unless specified otherwise, all amounts are in Canadian dollars.
“In 2014 we made significant progress advancing our strategic plan in key areas, including the clinical development of APL-130277 and strengthening our corporate leadership.
Help employers find you! Check out all the jobs and post your resume.
“In 2014 we made significant progress advancing our strategic plan in key areas, including the clinical development of APL-130277 and strengthening our corporate leadership.
Help employers find you! Check out all the jobs and post your resume.